Primary peritonectomy/hipec for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures

Surgeon

Volumn 7, Issue 6, 2009, Pages 345-350

  Zhu, K J ^a   Morris, D L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

appendiceal neoplasms; cytoreduction; cytoreductive surgery; intraperitoneal chemotherapy; peritoneal neoplasms; peritonectomy; pseudomyxoma peritoneii

Indexed keywords

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PERITONEAL CAVITY; PERITONEUM PSEUDOMYXOMA; PERITONEUM TUMOR;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; YOUNG ADULT;

EID: 73149101627     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(09)80108-X     Document Type: Article

References (25)

1. Sugarbaker P.H., Ronnett B.M., Archer A., et al. Pseudomyxoma peritonei syndrome. Adv Surg 30 (1996) 233-280
2. Ronnett B.M., Yan H., Kurman R.J., et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favourable prognosis than patients with peritoneal mucinosis carcinomatosis. Cancer 92 (2001) 85-91
3. Hinson F.L., and Ambrose N.S. Pseudomyxoma peritonei. Br J Surg 85 (1998) 1332-1339
4. Moran B.J., and Cecil T.D. The etiology, clinical presentation and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12 (2003) 585-603
5. Gough D.B., Donohue J.H., Schutt A.J., et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 219 (1994) 112-119
6. Miner T., Shia J., Jaques D., et al. Long-term survival following treatment of pseudomyxoma peritonei. Ann Surg 241 (2005) 300-308
7. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
8. Sugarbaker P.H. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27 (2001) 239-243
9. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
10. Sugarbaker P.H., Stuart O.A., and Yoo D. Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy. J Oncol Pharm Pract 11 (2005) 111
11. Witkamp A.J., de Bree E., Kaag M.M., et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88 (2001) 458-463
12. Jacquet P., and Sugarbaker P.H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res (1996)
13. Yan T., Black D., Savady R., et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for psuedomyxoma peritonei. Ann Surg Oncol 14 (2007) 484-492
14. Sugarbaker P.H. Are there curative options to peritoneal carcinomatosis?. Ann Surg 242 (2005) 748-750
15. Moran B.J., and Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Onc Cl N Am 12 (2003) 585-603
16. Smeenk R., Verwaal V., Antonini N., et al. Survival analysis of psuedomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245 (2007) 104-109
17. Verwaal V., Boot H., Aleman B., et al. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment and outcome. Ann Surg Oncol 11 (2004) 375-379
18. Smith J.W., Kemeny N., Caldwell C., et al. Pseudomyxoma peritonei of appendiceal origin: the Memorial Sloan-Kettering Cancer Center experience. Cancer 70 (1992) 396-401
19. Ronnett B.M., Yan H., Kurman R.J., et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92 (2001) 85-91
20. Deraco M., Baratti D., Inglese M.G., et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11 (2004) 393-398
21. Loungnarath R., Causeret S., Bossard N., et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 48 (2005) 1372-1379
22. Moran B.J., Mukherjee A., and Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg 93 (2006) 100-104
23. Bryant J., Clegg A.J., Sidhu M.K., et al. Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei. Br J Surg 92 (2005) 153-158
24. Guner Z., Schmidt U., Dahlke M.H., et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 20 (2004) 155-160
25. Elias D., Laurent S., Antoun S., et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol 27 (2003) 407-412